Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Schramke Mary L. — Solexa, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Schramke Mary L.

Schramke Mary L.

Acting CEO & VP Product Devel at Solexa, Inc. · on record since Dec 17, 2004

Insider trading activity of Schramke Mary L.

Transactions on record: 2; since Oct 27, 2004

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 17, 2004

Figures computed from official regulatory filings — methodology.

Companies where Schramke Mary L. has traded

Solexa, Inc.2 tx · Dec 17, 2004

Track record of Schramke Mary L.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Schramke Mary L.

Co-insiders of Schramke Mary L.

Abingworth Management LTDSolexa, Inc.
Allen SteveSolexa, Inc.
Amadeus Capital Partners LTDSolexa, Inc.
BARNES JEFFREY TSolexa, Inc.
BOWMAN A BLAINESolexa, Inc.
CARTHY MARKSolexa, Inc.
CORCORAN KEVIN PSolexa, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

DANIEL TOMSolexa, Inc.

FAMBROUGH DOUGLASSolexa, Inc.

FLEMING JONATHANSolexa, Inc.

HAUSER HERMANNSolexa, Inc.

HOOD LEROYSolexa, Inc.

ILLUMINA INCSolexa, Inc.

KAMIN PETER HSolexa, Inc.

KITCH JAMES CSolexa, Inc.

KOZIN MARC DSolexa, Inc.

Lloyd-Harris GenghisSolexa, Inc.

Lundberg PeterSolexa, Inc.

Lussier Richard HSolexa, Inc.

LYTTON MICHAELSolexa, Inc.

MITCHELL JAMES VSolexa, Inc.

Morfit G MasonSolexa, Inc.

MRNA FUND II LPSolexa, Inc.

OBP MANAGEMENT IV LPSolexa, Inc.

Omead OstadanSolexa, Inc.

OXFORD BIOSCIENCE PARTNERS IV LPSolexa, Inc.

Rubinstein Linda MSolexa, Inc.

SANROMAN KATHY ASolexa, Inc.

SCHRODER VENTURE MANAGERS LTDSolexa, Inc.

SCHRODER VENTURES INTERNATIONAL LIFE SCIENCES FUND II LP1Solexa, Inc.

Schroder Ventures International Life Sciences Fund II L.P.2Solexa, Inc.

Schroder Ventures International Life Sciences Fund II L.P.3Solexa, Inc.

Schroder Ventures International Life Sciences Fund II Strategic Partners L.P.Solexa, Inc.

SCHRODER VENTURES MANAGERS INCSolexa, Inc.

SIEGEL BROCK MSolexa, Inc.

SITCO Nominees Ltd. VC 01903 as Nominee of Schroder Ventures International Life Sciences Fund II Group Co-Investment SchemeSolexa, Inc.

Smith TonySolexa, Inc.

SV (Nominees) LTD as Nominee of Schroder Ventures Investments LTDSolexa, Inc.

TAYLOR CRAIG CSolexa, Inc.

UBBEN JEFFREY WSolexa, Inc.

UPRICHARD DAVID CSolexa, Inc.

VA PARTNERS LLCSolexa, Inc.

VASICEK THOMAS JSolexa, Inc.

WALTON ALAN GSolexa, Inc.

West JohnSolexa, Inc.

WHITFIELD ROY ASolexa, Inc.

WHITTERS JOSEPH ESolexa, Inc.

WOYCHIK RICHARD P PHDSolexa, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Solexa, Inc.	Dec 17, 2004	AwardD	5,000	3.90 USD	—	SEC
Solexa, Inc.	Oct 27, 2004	AwardD	6,000	2.96 USD	—	SEC